3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
3
Sarcoma
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Neoplasms
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Weight Loss
1
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Splenomegaly
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Interventions
Paclitaxel
2
Azacitidine
2
temsirolimus
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pembrolizumab
1
fludarabine
1
ceritinib
1
cc-486
1
carboxyamido-triazole
1
bemcentinib
1
acalabrutinib
1
abiraterone
1
Uncertainty
1
Thalidomide
1
Temozolomide
1
Sorafenib
1
Quality of Life
1
Psychosocial Intervention
1
Patient Reported Outcome Measures
1
Oxaliplatin
1
O(6)-benzylguanine
1
Molecular Diagnostic Techniques
1
Leucovorin
1
Lenalidomide
1
Interleukin-2
1
Interleukin-15
1
Injections
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Quality of Life
×
Other hematologic neoplasm
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled